Olink

Olink®
Part of Thermo Fisher Scientific

Filters

PublicationDisease areaApplication areaSample typeProducts

Advanced Science, 2025
Colorectal Cancer Cells–Derived Exosomal PIK3CA Mutation DNA Promotes Tumor Metastasis by Activating Fibroblast and Affecting Tumor Metastatic Microenvironment

Wang R., Li W., Lv Y. et al.

Olink Target 96OncologyPathophysiologyCell Culture Supernatant

Obesity Surgery, 2025
Changes in Inflammatory Markers Following Bariatric Surgery and the Impact of the Surgical Procedure: A 12-Month Longitudinal Study

Jensen R., Thuesen A., Huang Y. et al.

Olink Target 96Metabolic DiseasesPathophysiologyPlasma

Scientific Reports, 2025
Plasma inflammation-related proteins associated with anxiety and depression disorders in IBD patients

Zhou M., Zhang W., Dang Y. et al.

Olink Target 96Immunological & Inflammatory DiseasesNeurologyPathophysiologyPatient StratificationPlasma

Liver Cancer, 2025
Camrelizumab combined with Lenvatinib and RALOX-HAIC for unresectable hepatocellular carcinoma (Cal Era): a prospective, single-arm, phase II trial

Zang M., Li Q., Hu X. et al.

Olink Target 96OncologyImmunotherapyPatient StratificationSerum

Nature Communications, 2025
Multi-organ metabolome biological age implicates cardiometabolic conditions and mortality risk

Zalesky A., Tian Y., Ferrucci L. et al.

Olink Explore 3072/384CVDAgingPathophysiologyPlasma

Thrombosis Journal, 2025
Therapeutic targets for venous thromboemblism: proteome-wide mendelian randomization and colocalization analyses

Li X., Yang C., Zhou M. et al.

Olink Explore 3072/384HematologyPathophysiologyPlasma

Infection, 2025
Antigen-specific chemokine CCL3 as a biomarker for distinguishing between recent and remote tuberculosis infection

Chang C., Ma Z., Ren W. et al.

Olink Target 96Infectious DiseasesPatient StratificationPlasma

Journal of Inflammation Research, 2025
Using Olink Proteomics to Identify Inflammatory Biomarkers in the Cerebrospinal Fluid in Guillain-Barré Syndrome

Sun S., Li M., Song J. et al.

Olink Target 96NeurologyPatient StratificationCSF

Molecular Oncology, 2025
Systematic profiling of cancer‐fibroblast interactions reveals drug combinations in ovarian cancer

Gudoityte G., Sharma O., Leuenberger L. et al.

Olink Target 96OncologyPathophysiologyCell Culture Supernatant

International Journal of Cardiology Cardiovascular Risk and Prevention, 2025
Circulating protein biomarkers and their association with vulnerable plaque characteristics – a PROSPECT II substudy

Sharma T., Maehara A., Maeng M. et al.

Olink Target 96CVDPatient StratificationPlasma

Journal of Cardiac Failure, 2025
The Association between Serially Measured Circulating Biomarker Patterns and Pulmonary Artery Pressures measured by Invasive Hemodynamic Monitoring

de Jong M., Allach Y., Kamar S. et al.

Olink Target 96CVDPathophysiologyPlasma

Med, 2025
Pre-treatment untargeted cerebrospinal fluid metabolomic profiling in tuberculous meningitis uncovers pathways associated with mortality

Le T., van Abeelen K., Ardiansyah E. et al.

Olink Target 96Infectious DiseasesPathophysiologyCSF

Nature Communications, 2025
The health impacts and genetic architecture of food liking in cardio-metabolic diseases

Jiang W., Wang H., Geng Y. et al.

Olink Explore 3072/384CVDNutritional SciencePathophysiologyPlasma

Signal Transduction and Targeted Therapy, 2025
Harnessing local and system immune profiling delineating differential responders to first-line sintilimab (anti-PD-1 antibody) combined with chemotherapy in extensive-stage small cell lung cancer: an exploratory biomarker analysis of a phase II study

Xie M., Bao M., Dong X. et al.

Olink Target 96OncologyImmunotherapyPathophysiologyPatient StratificationPlasma

European Neuropsychopharmacology, 2025
Predicted plasma proteomics from genetic scores and treatment outcomes in major depression: a meta-analysis

Oliva V., Possidente C., Fanelli G. et al.

Olink Target 96NeurologyPathophysiologyPlasma

Nature Communications, 2025
FcRn-silencing of IL-12Fc prevents toxicity of local IL-12 therapy and prolongs survival in experimental glioblastoma

Beffinger M., Schellhammer L., Taskoparan B. et al.

Olink Target 96OncologyPathophysiologyTissue Culture Conditioned Medium

Circulation, 2025
Proteomic Signatures for Risk Prediction of Atrial Fibrillation

Park H., Norby F., Kim D. et al.

Olink Explore 3072/384CVDPatient StratificationPlasma

The American Journal of Clinical Nutrition, 2025
Relationship of healthy lifestyle with healthy aging and the mediation by plasma proteins: a prospective cohort study

Fang F., Liu Z., Lyu J. et al.

Olink Explore 3072/384AgingPathophysiologyPlasma

Medicine, 2025
Roles of plasma proteins in mediating the causal effect of the lipid species on gastric cancer: Insights from proteomic and two-step Mendelian randomization

Dong Z., Chen Z., Yu K. et al.

Olink Explore 3072/384OncologyCross-platform ValidationPlasma

Journal of Interferon & Cytokine Research, 2025
Significant Associations Between Blood Cell Counts and a Large Number of Salivary Cytokines, Chemokines, and Growth Factors

Eriksson L., Eriksson M., Gordh T. et al.

Olink Target 96Immunological & Inflammatory DiseasesPathophysiologySaliva

3494 publications